Table 5 Guideline for evaluation of pathogenic potential of genes with de novo variants in epileptic encephalopathies

From: Evaluating the pathogenic potential of genes with de novo variants in epileptic encephalopathies

Genes with de novo variants recurrently identified in unrelated cases are subject to further evaluation of pathogenic potential.

Possibly pathogenic with at least one of the following evidence:

1. Significantly high frequency or hotspot of variants in the patient group.

2. Other epilepsy-related phenotype with defined inheritance pattern.

3. Variants in the gene result in functional impairment that is related to epilepsy.

Pathogenic with at least one of the following specific evidence:

1. Variants of the gene are associated with characteristic phenotype.

2. Distinct correlation between genotype/funotype and phenotype.

3. Correlation between genetic impairment and phenotype severity, and it explains the severe phenotype.

4. Variant-specific model with corresponding phenotype, or defined mechanisms of epileptogenesis.